A citation-based method for searching scientific literature

J W Olney, N B Farber. Arch Gen Psychiatry 1995
Times Cited: 1283







List of co-cited articles
930 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Recent advances in the phencyclidine model of schizophrenia.
D C Javitt, S R Zukin. Am J Psychiatry 1991
27

Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Kate Merritt, Alice Egerton, Matthew J Kempton, Matthew J Taylor, Philip K McGuire. JAMA Psychiatry 2016
209
22

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
19

Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.
Camilo de la Fuente-Sandoval, Pablo León-Ortiz, Mariana Azcárraga, Sylvana Stephano, Rafael Favila, Leonardo Díaz-Galvis, Patricia Alvarado-Alanis, Jesús Ramírez-Bermúdez, Ariel Graff-Guerrero. JAMA Psychiatry 2013
132
16

Glutamate and dopamine in schizophrenia: an update for the 21st century.
Oliver Howes, Rob McCutcheon, James Stone. J Psychopharmacol 2015
392
16


The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
15

Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE).
A Egerton, B V Broberg, N Van Haren, K Merritt, G J Barker, D J Lythgoe, R Perez-Iglesias, L Baandrup, S W Düring, K V Sendt,[...]. Mol Psychiatry 2018
69
21

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.
John E Lisman, Joseph T Coyle, Robert W Green, Daniel C Javitt, Francine M Benes, Stephan Heckers, Anthony A Grace. Trends Neurosci 2008
715
15

Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.
Anouk Marsman, Martijn P van den Heuvel, Dennis W J Klomp, René S Kahn, Peter R Luijten, Hilleke E Hulshoff Pol. Schizophr Bull 2013
296
14

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
Lawrence S Kegeles, Xiangling Mao, Arielle D Stanford, Ragy Girgis, Najate Ojeil, Xiaoyan Xu, Roberto Gil, Mark Slifstein, Anissa Abi-Dargham, Sarah H Lisanby,[...]. Arch Gen Psychiatry 2012
234
12

Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.
Nina V Kraguljac, David M White, Meredith A Reid, Adrienne C Lahti. JAMA Psychiatry 2013
138
12

Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies.
Alice Egerton, Akarmi Bhachu, Kate Merritt, Grant McQueen, Agata Szulc, Philip McGuire. Front Psychiatry 2017
39
30

NMDA receptor hypofunction model of schizophrenia.
J W Olney, J W Newcomer, N B Farber. J Psychiatr Res 1999
708
12


Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers.
N V Kraguljac, M A Frölich, S Tran, D M White, N Nichols, A Barton-McArdle, M A Reid, M S Bolding, A C Lahti. Mol Psychiatry 2017
64
17

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.
A C Lahti, B Koffel, D LaPorte, C A Tamminga. Neuropsychopharmacology 1995
648
11

Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.
Nathan L Hutcheson, Meredith A Reid, David M White, Nina V Kraguljac, Kathy B Avsar, Mark S Bolding, Robert C Knowlton, Jan A den Hollander, Adrienne C Lahti. Schizophr Res 2012
54
18

Effects of ketamine in normal and schizophrenic volunteers.
A C Lahti, M A Weiler, B A Tamara Michaelidis, A Parwani, C A Tamminga. Neuropsychopharmacology 2001
450
10

GABAergic interneuron origin of schizophrenia pathophysiology.
Kazu Nakazawa, Veronika Zsiros, Zhihong Jiang, Kazuhito Nakao, Stefan Kolata, Shuqin Zhang, Juan E Belforte. Neuropharmacology 2012
311
10


Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology.
J M Stone, C Dietrich, R Edden, M A Mehta, S De Simoni, L J Reed, J H Krystal, D Nutt, G J Barker. Mol Psychiatry 2012
185
10

7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Meredith A Reid, Nouha Salibi, David M White, Timothy J Gawne, Thomas S Denney, Adrienne C Lahti. Schizophr Bull 2019
58
15

Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.
Camilo de la Fuente-Sandoval, Pablo León-Ortiz, Rafael Favila, Sylvana Stephano, David Mamo, Jesús Ramírez-Bermúdez, Ariel Graff-Guerrero. Neuropsychopharmacology 2011
176
9


Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.
Scott A Schobel, Nashid H Chaudhury, Usman A Khan, Beatriz Paniagua, Martin A Styner, Iris Asllani, Benjamin P Inbar, Cheryl M Corcoran, Jeffrey A Lieberman, Holly Moore,[...]. Neuron 2013
317
9

Reviewing the ketamine model for schizophrenia.
Joel Frohlich, John D Van Horn. J Psychopharmacol 2014
169
9

RETRACTED: Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction.
Nina Vanessa Kraguljac, Matthew Carle, Michael A Frölich, Steve Tran, Michael A Yassa, David Matthew White, Abhishek Reddy, Adrienne Carol Lahti. Biol Psychiatry Cogn Neurosci Neuroimaging 2018
24
33

Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.
Nina Vanessa Kraguljac, Meredith Reid, David White, Rebecca Jones, Jan den Hollander, Deborah Lowman, Adrienne Carol Lahti. Psychiatry Res 2012
137
8

Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies.
Yusuke Iwata, Shinichiro Nakajima, Eric Plitman, Yukiko Mihashi, Fernando Caravaggio, Jun Ku Chung, Julia Kim, Philip Gerretsen, Masaru Mimura, Gary Remington,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2018
31
25


Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis.
Alice Egerton, James M Stone, Christopher A Chaddock, Gareth J Barker, Ilaria Bonoldi, Rachel M Howard, Kate Merritt, Paul Allen, Oliver D Howes, Robin M Murray,[...]. Neuropsychopharmacology 2014
65
12

Animal models of schizophrenia.
C A Jones, D J G Watson, K C F Fone. Br J Pharmacol 2011
434
8

The dysconnection hypothesis (2016).
Karl Friston, Harriet R Brown, Jakob Siemerkus, Klaas E Stephan. Schizophr Res 2016
244
7

Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.
Meredith A Reid, Luke E Stoeckel, David M White, Kathy B Avsar, Mark S Bolding, N Shastry Akella, Robert C Knowlton, Jan A den Hollander, Adrienne C Lahti. Biol Psychiatry 2010
91
7

Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
Juan R Bustillo, Thomas Jones, Hongji Chen, Nicholas Lemke, Christopher Abbott, Clifford Qualls, Shannon Stromberg, Jose Canive, Charles Gasparovic. Schizophr Bull 2017
30
23

Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.
Eline M P Poels, Lawrence S Kegeles, Joshua T Kantrowitz, Daniel C Javitt, Jeffrey A Lieberman, Anissa Abi-Dargham, Ragy R Girgis. Schizophr Res 2014
110
7


NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.
John H Krystal, D Cyril D'Souza, Daniel Mathalon, Edward Perry, Aysenil Belger, Ralph Hoffman. Psychopharmacology (Berl) 2003
402
7

NMDA receptor and schizophrenia: a brief history.
Joseph T Coyle. Schizophr Bull 2012
258
7

Cortical inhibitory neurons and schizophrenia.
David A Lewis, Takanori Hashimoto, David W Volk. Nat Rev Neurosci 2005
7

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.
David A Lewis, Allison A Curley, Jill R Glausier, David W Volk. Trends Neurosci 2012
673
7

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review.
James M Stone, Paul D Morrison, Lyn S Pilowsky. J Psychopharmacol 2007
250
7

Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk.
Junjie Wang, Yingying Tang, Tianhong Zhang, Huiru Cui, Lihua Xu, Botao Zeng, Yu Li, Gaiying Li, Chunbo Li, Hui Liu,[...]. Neural Plast 2016
23
30

Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.
Elias Mouchlianitis, Michael A P Bloomfield, Vincent Law, Katherine Beck, Sudhakar Selvaraj, Naresh Rasquinha, Adam Waldman, Federico E Turkheimer, Alice Egerton, James Stone,[...]. Schizophr Bull 2016
105
7


Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Tatsunobu Natsubori, Hideyuki Inoue, Osamu Abe, Yosuke Takano, Norichika Iwashiro, Yuta Aoki, Shinsuke Koike, Noriaki Yahata, Masaki Katsura, Wataru Gonoi,[...]. Schizophr Bull 2014
79
8

Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.
James M Stone, Fern Day, Helen Tsagaraki, Isabel Valli, Mary A McLean, David J Lythgoe, Ruth L O'Gorman, Gareth J Barker, Philip K McGuire. Biol Psychiatry 2009
174
7


Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis.
A Egerton, G Modinos, D Ferrera, P McGuire. Transl Psychiatry 2017
75
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.